Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 7, 1996, Pages 1415-1428

  Tyagi, Suresh C ^a   Kumar, Suresh G ^a   Haas, Steven J ^a   Reddy, Hanumanth K ^a   Voelker, Donald J ^a   Hayden, Melvin R ^a   Demmy, Todd L ^a   Schmaltz, Richard A ^a   Curtis, Jack J ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Cardiomyopathy; Collagen; Collagenase; End stage heart failure; Extracellular matrix; Gene expression; Human ischemic heart disease; Infarction; Matrix metalloproteinase; Plasmin; Plasminogen activator; Remodeling; Tissue inhibitor of metalloproteinase;

Indexed keywords

COLLAGEN; COLLAGENASE; GELATINASE; HEART ENZYME; MESSENGER RNA; METALLOPROTEINASE; PHENANTHROLINE; PLASMIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE PLASMINOGEN ACTIVATOR;

ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HEART FAILURE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INTERSTITIUM; ISCHEMIC HEART DISEASE; ISOELECTRIC POINT; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

EID: 0030199245     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0132     Document Type: Article

References (55)

1. AGREN MS, TAPLIN CJ, WOESSNER JR, JF, ELAGLSTEIN WH, MERTZ PM, 1992. Collagenase in wound healing: effect of wound age and type. J Invest Dermatol 9: 709-714.
2. ALEXANDER CM, WERB Z, 1989. Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol 1: 974-82.
3. ARAI M, ALPERT NR, MACLENNAN DH, BARTON P, PERIASAMY M, 1993. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for the alterations in systolic and diastolic properties of the failing myocardium. Circ Res 72, 463-469.
4. BRADFORD MM, 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. CANNON RO, BUTANY JW, MCMANUS BM, SPEIR E, KRAVITS AB, BILLI R, FERRANS VJ, 1983. Early degradation of collagen after acute myocardial infarction in the rat. Am J Cardiol 52: 390-395.
6. CHIN J, MURPHY G, WERB Z, 1985. Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. J Biol Chem 260: 12367-76.
7. CHURGWIN JM, PRZBYLA AZ, MACDONAL RJ, RUTTER WJ, 1979. Isolation of biological active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 132: 6-13.
8. DANO K, ANDREASEN PA, GRONDAHL-HANSEN J, KRISTENSEN P, NIELSEN LS, SKRIVER L, 1985. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44: 139-266.
9. FELDMAN AM, RAY PE, SILAN CM, MERCER JA, MINOBE W, BRISTOW MR, 1991. Selective gene expression in failing human heart: quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction, Circulation 83: 1866-1872.
10. GRAY RP, YUDKING JS, PATTERSON DL, 1993. Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor? Brit Heart J 70: 530-536.
11. GRAY RP, YUDKIN JS, PATTERSON DL, 1993. Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients. Brit Heart J 69: 228-232.
12. GROSS J, NAGAI Y, 1965. Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc Natl Acad Sci USA 54: 1197-1204.
13. HARPER E, 1980. Collagenases. Annu Rev Biochem 49: 1063-1078.
14. HARPER E, BLOCK KJ, GROSS J, 1971. The zymogen of tadpole collagenase. Biochemistry 10: 3035-3041.
15. HANTAI D, FESTOFF BW, 1987. Degradation of muscle basement membrane zone by locally generated plasmia. Experi Neurol 95: 44-55.
16. HERRON GS, WERB Z, DWYER K, BANDA MJ, 1986. Secretion of metalloproteinases by stimulated capillary endothelial cells: production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J Biol Chem 261: 2810-2813.
17. HUBER R, CARRELL RW, 1989. Implications of the three dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry 28: 8951-8966.
18. IIMOTO DS, COVELL JW, HARPER E, 1988. Increase in cross-linking type I and III collagens associated with volume-overload hypertrophy. Circ Res 63: 399-408.
19. JANICKI JS, TYAGI SC, MATSUBARA BB, CAMPBELL SE, 1994. Structural and functional consequences of myocardial collagen remodeling. In: Hori M, Maruyama Y, Reneman RS, eds, Cardiac Adaptation and Failure, Springer-Verlag: Tokyo, 279-289.
20. KABOUR A, HENEGAR JR, JANICKI JS, 1994. Angiotensin II-induced myocyte necrosis: role of the angiotensin II receptor. J Cardiovasc Pharmacol 23: 547-553.
21. KESKI-OJA J, LOHI J, TUUTTILA A, TRYGGVASON K, VARTIO T, 1992. Proteolytic processing of the 72 kDa type IV colleganase by urokinase plasminogen activator. J Exp Cell Res 202: 471-476.
22. KOHKHA R, DENHARDT DT, 1989. Matrix metalloproteinases and tissue inhibitor of metalloproteinases: A review of their role in tumorigensis and tissue invasion. Invasion Metastasis 9: 391-405.
23. 4. Nature 227: 680-85.
24. LAZARUS GS, BROWN RS, DANIELS JR, FULLMER HM, 1968. Human granulocyte collagenase. Science 159: 1483-1484.
25. LIOTTA LA, STEEG PS, STETLER-STEVENSON WG, 1991. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336.
26. MATRISIAN LM, 1990. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121-125.
27. MIGNATTI P, ROBBINS E, RIFKIN DB, 1986. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47: 487-498.
28. NORRIS RM, OCKELFORD PA, CROSS DB, RIVERS JT, SMITH JM, TAKAYAMA M, WHITE HD, 1992. Reduced synthesis of tissue plasminogen activator by vascular endothelium during acute myocardial infarction. Austr New Zeal J Med 22: 261-264.
29. OKADA Y, TAKEUCHI N, NAKANISHI I, NAGASE H, 1989. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis 48: 575-653.
30. OLIVETTI G, CAPASSO JM, SONNENBLICK EG, ANVERSA P, 1990. Side-to side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res 67: 23-34.
31. PAULY RR, PASSANITI A, BILATO C, MONTICONE R, CHENG L, PAPADOPOULOS N, GLUZBAND YA, SMITH L, WEINSTEIN C, LAKATTA EG, CROW MT, 1994. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 45: 41-54.
32. PEUHKURINEN KJ, RISTELI L, MELKKO JT, LINNALUOTO M, JOUNELA A, RISTELI J, 1991. Thrombolytic therapy with streptokinase stimulates collagen breakdown. Circulation 83: 1969-1975.
33. PYKE C et al., 1991. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 148: 1059-1067.
34. RUCKLIDGE GJ, MILNE G, McGAW BA, MILNE E, ROBINS SP, 1992. Turnover rates of different collagen types measured by isotype ratio mass spectrometry. Biochim Biophys Acta 1156: 57-61.
35. SATO H, TAKINO T, OKADA Y, CAO J, SHINAGAWA A, YAMAMOTO E, SEIKI M, 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65.
36. SHIMAMORI Y, WARANABE Y, FUJIMOTO Y, 1995. Characterization of gelatinases in human placenta. Biochem Mol Med 56: 84-86.
37. SUZUKI K, ENGHILD JJ, MORODOMI T, SALVESEN G, NAGASE H, 1990. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29: 10261-10270.
38. TEMPLETON DM, 1988. The basis and applicability of the dimethylmethylene blue assay for sulfated glycosaminoglycans. Connect Tiss Res 17: 23-32.
39. TRAVIS J, GUZDEK A, POTEMPA W, WATOREK W, 1990. Serpins: structure and mechanisms of action. Biol Chem Hoppe Seyler 371: 3-11.
40. TRYGGVASON K, HOYHTYA M, SALO T, Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 907: 191-217, 1987.
41. TYAGI SC, SIMON SR, 1990. Inhibitors directed to binding domain in neutrophil elastase. Biochemistry 29: 9970-9977.
42. TYAGI SC, RATAJASKA A, WEBER KT, 1993a. Myocardial matrix metalloproteinase: activation and localization. Mol Cell Biochem 126: 49-59.
43. TYAGI SC, MATSUBARA L, WEBER KT, 1993b. Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem 26: 191-198.
44. TYAGI SC, REDDY HK, VOELKER DJ, TIAHJE E, SHAW B, WEBER KT, 1993c. Myocardial collagenase and tissue inhibitor in dilated, failing human myocardium. Circulation 88: 1-407.
45. TYAGI SC, KUMAR SG, GLOVER G, 1995a. Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart-derived fibroblast and endomyocardial endothelial cells. J Cell Biochem 58: 360-372.
46. TYAGI SC, REDDY HK, CAMPBELL SE, WEBER KT, 1995b. Myocardial collagenase in failing human heart. In: Weber KT, ed, Wound Healing in Cardiovascular Disease, Futura Publishing Co: Boston 67-72.
47. TYAGI SC, KUMAR SG, BANKS J, FORTSON W, 1995c. Co-expression of Tissue Inhibitor and Matrix Metalloproteinase in Myocardium. J Mol Cell Cardiol 27: 2177-2189.
48. VAES G, 1971. A latent collagenase by bone and skin explants in culture. Biochem J 123: 23-24.
49. VALLE KJ, BAUER EA, 1980. Enhanced biosynthesis of human collagenase in fibroblast cultures from recessive dystrophic epidermolysis bullosa. J Clin Invest 66: 176-187.
50. WARD RV, HEMBRY RM, REYNOLDS JJ, MURPHY G, 1991. The purification of tissue inhibitor of metalloproteinase-2 (TLMP-1) from its 72 kDa progelatinase complex; Demonstration of the biochemical similarities of TLMP-2 and TLMP-1. Biochem J 278: 179-187.
51. WEBER KT, SUN Y, TYAGI SC, CLEUTJENS J, 1994. Collagen network of the myocardium: Functional, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26: 219-292.
52. WERB Z, MAINARDI CL, VATER CA, HARRIS ED JR, 1977. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med 296: 1017-1023.
53. WOESSNER JF, JR, 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling, FASEB J 5: 2145-2154.
54. WU H, BYRNE MH, STACEY A, GOLDRING MB, BIRKHEAD JR, JAENSICH R, KRANE SM, 1990. Generation of collagenase-resistant collagen by site-directed mutagenesis of murine pro alpha 1 collagen gene. Proc Natl Acad Sci USA 87: 5888-5892.
55. YOUNG HL, WHEELER MH, 1983. Effect of intravenous aprotinin (trasylol) on the healing of experimental colonic anastomoses in the rabbit. Eur Surg Res 15: 18-23.